183 related articles for article (PubMed ID: 18573723)
1. Effective control of psoriasis by etanercept in a patient with HCV-related diseases.
Piccolo D; Di Cesare A; Fargnoli MC; Paoloni M; Vecchiotti S; Peris K
Eur J Dermatol; 2008; 18(4):459-60. PubMed ID: 18573723
[No Abstract] [Full Text] [Related]
2. Etanercept therapy in two patients with psoriasis and concomitant hepatitis C.
De Simone C; Paradisi A; Capizzi R; Carbone A; Siciliano M; Amerio PL
J Am Acad Dermatol; 2006 Jun; 54(6):1102-4. PubMed ID: 16713482
[No Abstract] [Full Text] [Related]
3. Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection.
Alcaide AJ; Barrera MV; Habicheyn S; López N; Mendiola MV; Herrera E
J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1514-6. PubMed ID: 18355196
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of etanercept in patients with psoriasis and hepatitis C.
Ventura F; Gomes J; Duarte Mda L; Fernandes JC; Brito C
Eur J Dermatol; 2010; 20(6):808-9. PubMed ID: 20923749
[No Abstract] [Full Text] [Related]
5. Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant.
Collazo MH; González JR; Torres EA
P R Health Sci J; 2008 Dec; 27(4):346-7. PubMed ID: 19069362
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of etanercept for psoriasis in daily practice.
Van Lümig PP; Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM
Br J Dermatol; 2012 Feb; 166(2):445-7. PubMed ID: 21910699
[No Abstract] [Full Text] [Related]
7. Etanercept: effectiveness and safety data of a retrospective study.
Antoniou C; Vergou T; Dessinioti C; Stratigos AJ; Avgerinou G; Stavropoulos P; Katsambas A
J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1113-5. PubMed ID: 20673305
[No Abstract] [Full Text] [Related]
8. Etanercept in the treatment of psoriasis and psoriatic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients.
Zanni M; Missale G; Santilli D; Di Nuzzo S
Eur J Dermatol; 2011; 21(4):564-7. PubMed ID: 21543290
[TBL] [Abstract][Full Text] [Related]
9. Is etanercept safe for treating plaque psoriasis in a patient with chronic hepatitis C virus infection?
Gandhi RK; Pickup T; Sheth PB
Arch Dermatol; 2010 Oct; 146(10):1151-2. PubMed ID: 20956650
[No Abstract] [Full Text] [Related]
10. Successful treatment of systemic cold contact urticaria with etanercept in a patient with psoriasis.
Gualdi G; Monari P; Rossi MT; Crotti S; Calzavara-Pinton PG
Br J Dermatol; 2012 Jun; 166(6):1373-4. PubMed ID: 22212112
[No Abstract] [Full Text] [Related]
11. Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept).
Cecchi R; Bartoli L
Dermatol Online J; 2006 Dec; 12(7):4. PubMed ID: 17459290
[TBL] [Abstract][Full Text] [Related]
12. Etanercept does not have an apoptosis-inducing effect on psoriatic keratinocytes.
Tatlican S; Arikok A; Gulbahar O; Eren C; Cevirgen B; Eskioglu F
J Dermatolog Treat; 2010 Sep; 21(5):306-10. PubMed ID: 19878038
[TBL] [Abstract][Full Text] [Related]
13. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection.
Rokhsar C; Rabhan N; Cohen SR
J Am Acad Dermatol; 2006 Feb; 54(2):361-2. PubMed ID: 16443079
[No Abstract] [Full Text] [Related]
14. Etanercept combined with methotrexate for high-need psoriasis.
Driessen RJ; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
[TBL] [Abstract][Full Text] [Related]
15. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
[TBL] [Abstract][Full Text] [Related]
16. Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data.
Paradisi A; Caldarola G; Capizzi R; Siciliano M; Annichiarico E; Vecchio FM; Amerio PL; De Simone C
J Am Acad Dermatol; 2010 Jun; 62(6):1067-9. PubMed ID: 20466184
[No Abstract] [Full Text] [Related]
17. Development of pemphigus vulgaris in a patient with psoriasis treated with etanercept.
Daulat S; Detweiler JG; Pandya AG
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):483-4. PubMed ID: 18793242
[No Abstract] [Full Text] [Related]
18. Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study.
Woolf RT; Smith CH; Robertson K; Barker JN
Br J Dermatol; 2010 Oct; 163(4):889-92. PubMed ID: 20854408
[No Abstract] [Full Text] [Related]
19. Long-term management of HIV/hepatitis C virus associated psoriasis with etanercept.
Di Lernia V; Zoboli G; Ficarelli E
Indian J Dermatol Venereol Leprol; 2013; 79(3):444. PubMed ID: 23619459
[No Abstract] [Full Text] [Related]
20. Etanercept in a patient with severe psoriasis and latent viral hepatic disease and latent tuberculosis.
Prestinari F; Ferguglia G; Laria G
Am J Clin Dermatol; 2010; 11 Suppl 1():57-8. PubMed ID: 20586514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
